pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

20,113 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: recall×type: approval×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area

    no tagged catalysts yet

    Week of Oct 6, 2025

    2
    ›Oct 10, 2025approval324d agoLAMICTAL XR (LAMOTRIGINE) — FDA approvalLAMOTRIGINE

    Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Oct 10, 2025approval324d agoRINVOQ (UPADACITINIB) — FDA approvalupadacitinib tartrate ER

    Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →upadacitinib tartrate ER →fda approvals ↗

    Week of Oct 13, 2025

    48
    ›Oct 14, 2025approval320d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

    Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Oct 14, 2025approval
    ← prev
    page 349 of 403
    next →
    320d ago
    SAXENDA (LIRAGLUTIDE) — FDA approvalNovo Nordisk Inc

    Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Oct 14, 2025approval320d agoXULTOPHY 100/3.6 (INSULIN DEGLUDEC) — FDA approvalNovo Nordisk Inc

    Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Oct 14, 2025approval320d agoEPINEPHRINE — FDA approvaladrenaline

    Sponsor: AMNEAL. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

    full page →adrenaline →fda approvals ↗
    ›Oct 14, 2025approval320d agoVICTOZA (LIRAGLUTIDE) — FDA approvalSaxenda

    Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →Saxenda →fda approvals ↗
    ›Oct 14, 2025approval320d agoOZEMPIC (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

    Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Oct 14, 2025approval320d agoOZEMPIC (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

    Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Oct 15, 2025approval319d agoCELECOXIB — FDA approvalCelebrex

    Sponsor: YILING. Form: CAPSULE. Route: ORAL

    full page →Celebrex →fda approvals ↗
    ›Oct 15, 2025approval319d agoCELECOXIB — FDA approvalCelebrex

    Sponsor: YILING. Form: CAPSULE. Route: ORAL

    full page →Celebrex →fda approvals ↗
    ›Oct 15, 2025approval319d agoFINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approvalfenfluramine hydrochloride

    Sponsor: UCB INC. Form: SOLUTION. Route: ORAL

    full page →fenfluramine hydrochloride →fda approvals ↗
    ›Oct 15, 2025approval319d agoLACOSAMIDE — FDA approvalLACOSAMIDE

    Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL

    full page →LACOSAMIDE →fda approvals ↗
    ›Oct 15, 2025approval319d agoLACOSAMIDE — FDA approvalLACOSAMIDE

    Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL

    full page →LACOSAMIDE →fda approvals ↗
    ›Oct 15, 2025approval319d agoLACOSAMIDE — FDA approvalLACOSAMIDE

    Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL

    full page →LACOSAMIDE →fda approvals ↗
    ›Oct 15, 2025approval319d agoLACOSAMIDE — FDA approvalLACOSAMIDE

    Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL

    full page →LACOSAMIDE →fda approvals ↗
    ›Oct 15, 2025approval319d agoLACOSAMIDE — FDA approvalLACOSAMIDE

    Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL

    full page →LACOSAMIDE →fda approvals ↗
    ›Oct 15, 2025approval319d agoCONJUGATED ESTROGENS (ESTROGENS, CONJUGATED) — FDA approvalIngenus Pharmaceuticals LLC

    Sponsor: NOVAST LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 15, 2025approval319d agoCONJUGATED ESTROGENS (ESTROGENS, CONJUGATED) — FDA approvalIngenus Pharmaceuticals LLC

    Sponsor: NOVAST LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 15, 2025approval319d ago— FDA approvalMerck Sharp & Dohme LLC

    Sponsor: MERCK SHARP AND DOHME LLC

    full page →fda approvals ↗
    ›Oct 15, 2025approval319d agoLYTGOBI (FUTIBATINIB) — FDA approvalfutibatinib

    Sponsor: TAIHO ONCOLOGY. Form: TABLET. Route: ORAL

    full page →futibatinib →fda approvals ↗
    ›Oct 15, 2025approval319d agoPANTOPRAZOLE SODIUM — FDA approvalPANTOPRAZOLE SODIUM

    Sponsor: ASPIRO. Form: INJECTABLE. Route: INTRAVENOUS

    full page →PANTOPRAZOLE SODIUM →fda approvals ↗
    ›Oct 15, 2025approval319d agoPANTOPRAZOLE SODIUM — FDA approvalPANTOPRAZOLE SODIUM

    Sponsor: ASPIRO. Form: INJECTABLE. Route: INTRAVENOUS

    full page →PANTOPRAZOLE SODIUM →fda approvals ↗
    ›Oct 15, 2025approval319d agoAMLODIPINE BESYLATE AND VALSARTAN (AMLODIPINE BESYLATE) — FDA approvalamlodipine besylate

    Sponsor: TORRENT. Form: TABLET. Route: ORAL

    full page →amlodipine besylate →fda approvals ↗
    ›Oct 15, 2025approval319d agoAMLODIPINE BESYLATE AND VALSARTAN (AMLODIPINE BESYLATE) — FDA approvalamlodipine besylate

    Sponsor: TORRENT. Form: TABLET. Route: ORAL

    full page →amlodipine besylate →fda approvals ↗
    ›Oct 15, 2025approval319d agoLIRAGLUTIDE — FDA approvalNovo Nordisk Inc

    Sponsor: NANJING KING FRIEND. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    Reconstitution XO Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health a) 5% Exosomes, 10 mL vial and b) 10% Exosomes, 5 mL vial, Extension Health a) 20% Exosomes, 10 mL vial, b) 10% Exosomes, 10 mL vial and Medical Health Institute (MHI), a) 10 % Exosomes, 2mL vial, 5mL vial, 10mL vial, b) 5% Exosomes, 2mL vial, 5mL vial, 10mL vial. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)Baylor College of Medicine

    Glycine for Injection, all strengths and presentations, GenoGenix LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    GHK-Cu (Copper Peptide) for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)Tsuno Rice Fine Chemicals Co Ltd

    Magnesium Chloride for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)EVER Neuro Pharma GmbH

    Cerebrolysin for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    L-Carnitine for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)Baudax Bio Inc

    N-Acetyl-L-Cysteine for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL, b) 100 mg/mL, 10 mL multi-dose vials, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)Nexus Pharmaceuticals Inc

    Methylene Blue for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoAvKARE recall (Cls II)AvKare LLC

    Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28 — Reason: Failed Content Uniformity Specifications — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    Lysine for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    Biotin for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)Amneal Pharmaceuticals, Inc.

    Calcium Chloride for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    Amino Blend for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    Tesamorelin for Injection, 15mg, 10 mL Multi-Dose Vial, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)Eli Lilly and Co

    Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Extension Health and Synergy Wellness 60mg, 10mL vial lyophilized. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    Bacteriostatic Water for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health, Extension Health and Medical Health Institute — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)University of Colorado Denver

    Taurine for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    L-Arginine for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    Tri-Immune for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recall (Cls II)Fosun Pharma USA Inc

    Major ChlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7133-61, UPC (01)00309047133611 NDC 0904-7133-61 — Reason: CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    Vitamin D3 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)PharmaTher Holdings Ltd

    BPC-157 for Injection, 15mg/10mL vial, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Medical Health Institute (MHI), 15mg, 10mL vial lyophilized. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Oct 15, 2025recall319d agoGenoGenix LLC recall (Cls II)

    Retatrutide for Injection, 60mg / 10mL vial, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    $ABBV255.48-1.03%
    $AMRX17.54-2.61%
    $NVO45.61-1.41%
    $AMRX17.54-2.61%